Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
GMI-1070, PF-06460031
print preview
bookmark
share with colleague
General Information
Company
GlycoMimetics Inc.
Description
Glycomimetic inhibitor of E selectin (SELE; CD62E), P selectin (SELP; CD62P) and L selectin (CD62L; SELL)
Molecular Target
E selectin (SELE) (CD62E)
;
P selectin (SELP) (CD62P)
Mechanism of Action
Pan-selectin antagonist
Latest Stage of Development
Phase II
Indication
Sickle cell disease
Partner
Pfizer Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy